You have 9 free searches left this month | for more free features.

refractory brain cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

Recruiting
  • Glioblastoma
  • +8 more
  • Intra-arterial Cetuximab
  • +2 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 17, 2022

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

Brain Tumor, Primary Trial in Jinan (HLX208)

Recruiting
  • Brain Tumor, Primary
  • Jinan, Shandong, China
    Cancer Hospital Affiliated to Shandong first medical University
May 1, 2022

Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • +3 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022

Brain Tumor, Medulloblastoma, Brain Metastases Trial in Atlanta (WP1066)

Recruiting
  • Brain Tumor
  • +2 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta (CHOA)
Jul 24, 2022

Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)

    Terminated
    • Brain and Central Nervous System Tumors
    • Chicago, Illinois
      Rush Cancer Institute at Rush University Medical Center
    Jan 5, 2023

    Malignant Brain Tumor, Malignant Glioma, Embryonal Tumor Trial in Paris, Villejuif (SonoCloud® (9 transducers))

    Not yet recruiting
    • Malignant Brain Tumor
    • +2 more
    • SonoCloud® (9 transducers)
    • Paris, France
    • +2 more
    Sep 26, 2022

    Malignant Brain Tumor, Recurrent Malignant Brain Tumor, Refractory Malignant Brain Tumor Trial in Duarte (Cyclophosphamide,

    Recruiting
    • Malignant Brain Neoplasm
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    May 19, 2022

    Solid Tumors, Primary Brain Tumors Trial in United States (Vincristine, Irinotecan, Temozolomide)

    Completed
    • Solid Tumors
    • Primary Brain Tumors
    • Hartford, Connecticut
    • +13 more
    Jan 12, 2023

    Precision Medicine for Every Child With Cancer

    Recruiting
    • Childhood Cancer
    • +5 more
    • Whole Genome Sequencing
    • +6 more
    • Adelaide, Australia
    • +8 more
    Jan 24, 2023

    Astrocytoma, Brain Cancer, Brain Metastases Trial in Kogarah, Liverpool (QBS10072S)

    Recruiting
    • Astrocytoma
    • +22 more
    • Kogarah, New South Wales, Australia
    • +1 more
    Apr 18, 2022

    Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas Trial in Canada, United States (Vemurafenib)

    Active, not recruiting
    • Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas
    • Los Angeles, California
    • +20 more
    Jan 4, 2023

    Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

    Completed
    • Ependymoma
    • +9 more
    • Nivolumab
    • NKTR-214
    • Little Rock, Arkansas
    • +17 more
    Dec 8, 2022

    Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United

    Completed
    • Neurofibromatosis Type 1
    • +4 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Los Angeles, California
    • +11 more
    Apr 22, 2022

    Refractory and Relapsed Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guangzhou (Orelabrutinib, Thiotepa)

    Not yet recruiting
    • Refractory and Relapsed Primary CNS Lymphoma
    • +2 more
    • Guangzhou, Guangdong, China
      Department of Medical Oncology, Sun Yat-sen University Cancer Ce
    Aug 19, 2021

    Deep Brain Stimulation Trial in Shanghai (deep brain stimulation)

    Recruiting
    • Deep Brain Stimulation
    • deep brain stimulation
    • Shanghai, China
      Shanghai Mental Health Center
    Nov 6, 2023

    Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)

    Recruiting
    • Pediatric Solid Tumor
    • +7 more
    • CLR 131
    • Palo Alto, California
    • +6 more
    Nov 30, 2021

    Opioid-Related Disorders Trial in Morgantown (Deep Brain Stimulation)

    Recruiting
    • Opioid-Related Disorders
    • Deep Brain Stimulation
    • Morgantown, West Virginia
      West Virginia University Rockefeller Neuroscience Institute
    Jun 13, 2023

    OCD Trial in Petah tikva (Deep Bran Stimulation (DBS), Sham-stimulation)

    Recruiting
    • Obsessive-Compulsive Disorder
    • Deep Bran Stimulation (DBS)
    • Sham-stimulation
    • Petah tikva, Israel
      Rabin Medical Center
    Aug 10, 2023

    Hypoxia-Ischemia, Brain, Heart Arrest, Status Epilepticus Trial in San Francisco (Burst Suppression EEG Target Intravenous

    Not yet recruiting
    • Hypoxia-Ischemia, Brain
    • +6 more
    • Burst Suppression EEG Target Intravenous Anesthesia
    • Seizure Suppression EEG Target Intravenous Anesthesia
    • San Francisco, California
      Zuckerberg San Francisco General Hospital
    May 1, 2023